Table 2 Immunological and treatment parameters at the initiation of therapy
From: Outcome of highly active antiretroviral therapy in HIV- infected Indian children
Parameter | Values |
|---|---|
Duration of follow up while on HAART, months, median (IQR) | 43 (17,68) |
CD4 count, cells/μL, median (IQR) | 340 (185,704) |
Age <2 years (n = 27) | 424 (304,729) |
Age 2-5years (n = 20) | 460 (260,871) |
Age >5 years (n = 128) | 288 (163,639) |
CD4%, mean (SD) | 13.3 (10.7) |
Baseline regime of HAART, n (%) | |
d4T+3TC+NVP | 141 (80.6) |
d4T+3TC+EFV | 19 (10.8) |
AZT+3TC+NVP | 11 (6.3) |
AZT+3TC+EFV | 4 (2.3) |